SCHEMBL30582605

SCHEMBL30582605

Cn1c(C2=CCC3(CCNCC3)CC2)c(-c2ccc(F)cc2)c2c(N)ncnc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNT1 O60563 1/20 0.38
▸ CDK9 P50750 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ RIPK2 O43353 1/20 0.36
▸ BTK Q06187 1/20 0.35
▸ LRRK2 Q5S007 2/20 0.35
▸ EIF2AK3 Q9NZJ5 1/20 0.34
▸ RET P07949 1/20 0.33
▸ DGAT1 O75907 1/20 0.33
▸ RPS6KB1 P23443 2/20 0.33
▸ FYN P06241 1/20 0.33
▸ YES1 P07947 1/20 0.33
▸ EPHA2 P29317 1/20 0.33
▸ RPS6KA3 P51812 1/20 0.33
▸ VCP P55072 1/20 0.33
▸ HDAC1 Q13547 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26106044 1.00 CCNT1 (0.38) CCNT1CDK9KDM4EALDH1A1LMNA
SCHEMBL30582620 0.89 RIPK2 (0.40) CCNT1CDK9RIPK2LRRK2EIF2AK3
SCHEMBL26109630 0.89 RIPK2 (0.40) CCNT1CDK9RIPK2LRRK2EIF2AK3
SCHEMBL30582544 0.89 SRC (0.44) CCNT1CDK9KDM4EALDH1A1SMN1; SMN2
SCHEMBL26108026 0.89 SRC (0.44) CCNT1CDK9KDM4EALDH1A1SMN1; SMN2
SCHEMBL30582578 0.87 KIT (0.35) CCNT1CDK9BTKLRRK2SRC
SCHEMBL26106140 0.87 KIT (0.35) CCNT1CDK9BTKLRRK2SRC
SCHEMBL30582633 0.87 CCNT1 (0.34) CCNT1CDK9LRRK2SRCKDR
SCHEMBL26106109 0.87 CCNT1 (0.34) CCNT1CDK9LRRK2SRCKDR
SCHEMBL30582625 0.86 KCNH2 (0.39) SRCKDRABL1EGFRLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4499616-A1 SPIROBICYCLIC COMPOUNDS Acerand Therapeutics (Hong Kong) Limited (HK) 2025-02-05 — — EP disclosed
CN-119013260-A Spirobicyclic compounds 优领医药科技(香港)有限公司 2024-11-22 — — CN disclosed
WO-2023192502-A1 SPIROBICYCLIC COMPOUNDS ACERAND THERAPEUTICS (USA) LIMITED (US) 2023-10-05 — — WO disclosed
Send feedback